Clin Mol Hepatol > Volume 31(1); 2025 > Article
Pirola, Landa, Schuman, García, Salatino, and Sookoian: Metabolic dysfunction-associated steatotic liver disease exhibits sex-specific microbial heterogeneity within intestinal compartments

ABSTRACT

Background/Aims

Evidence suggests that the gastrointestinal microbiome plays a significant role in the biology of metabolic dysfunction-associated steatotic liver disease (MASLD). However, it remains unclear whether disparities in the gut microbiome across intestinal tissular compartments between the sexes lead to MASLD pathogenesis.

Methods

Sex-specific analyses of microbiome composition in two anatomically distinct regions of the gut, the small intestine and colon, were performed using an experimental model of MASLD. The study involved male and female spontaneously hypertensive rats and the Wistar-Kyoto control rat strain, which were fed either a standard chow diet or a high-fat diet for 12 weeks to induce MASLD (12 rats per group). High-throughput 16S sequencing was used for microbiome analysis.

Results

There were significant differences in the overall microbiome composition of male and female rats with MASLD, including variations in topographical gut regions. The beta diversity of the jejunal and colon microbiomes was higher in female rats than in male rats (PERMANOVA P-value=0.001). Sex-specific analysis and discriminant features using LEfSe showed considerable variation in bacterial abundance, along with distinct functional properties, in the jejunum and colon of animals with MASLD. Significantly elevated levels of lipopolysaccharide and protein expression of Toll-like receptor 4 were observed in the livers of male rats with MASLD compared with their female counterparts.

Conclusions

This study uncovered sexual dimorphism in the gut microbiome of MASLD and identified microbial heterogeneity within intestinal compartments. Insights into sex-specific variations in gut microbiome composition could facilitate customised treatment strategies.

Graphical Abstract

INTRODUCTION

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease (NAFLD) [1], is a complex process [2]. Recent highthroughput DNA sequencing technologies have revealed the crucial role of the body’s microbial community, particularly the intestinal microbiome, in the biology of liver diseases [3-10].
The gut-liver axis is crucial for the initiation and progression of MASLD [11,12]. This largely stems from the anatomical link between the liver and the gut via the venous portal system. Therefore, microbial signals can alter liver metabolism and inflammatory responses [11,13-15]. It is commonly acknowledged that the gastrointestinal system harbors the highest quantity of bacteria in the human body. The estimated number of bacteria in the large intestine of humans, which comprises over 1,000 known species, is of the order of magnitude of 1014. In the lower small intestine (ileum), it is 1011, whereas in the upper small intestine (duodenum and jejunum), it is 107 [16]. Most importantly, each anatomical region of the human intestine, including the small and large intestines, which are further subdivided within each region, presents specific and functionally linked unique properties, rather than a single continuous unit. For example, distinct functional compartments promote immune homeostasis [17]. Furthermore, the digestive system exhibits regional characteristics that affect dietary nutrient uptake in the small intestine. In contrast, the large intestine is exposed to a profuse microbiome and secondary metabolites produced by bacterial metabolism, including bile acids [17]. Interestingly, the variances in the gut microbiome between different anatomical regions have yet to be investigated in association with MASLD.
Similarly, the pathophysiology of MASLD is influenced by sex-related molecular signatures that impact complex regulatory pathways, such as patterns of fat deposition [18], fetal programmed-mitochondrial function [19], inflammatory response, and fibrogenesis [20-22], and genetic differences [23]. Furthermore, variations in the prevalence and progression of MASLD exist between males and females [24]. A number of experimental studies have demonstrated that the composition of the gut microbiota differs between the sexes [25-28].
Although sex is a key modifier of MASLD natural history, it remains unknown whether sexual dimorphism in the different intestinal compartments contributes to MASLD pathogenesis.
In this study, we conducted sex-specific microbiome analyses of the upper small intestine and colon, two anatomically distinct gut regions, using an experimental steatotic liver disease model that recapitulates human MASLD phenotypic features. We hypothesise that microbiome-derived inflammatory signals may influence the disease biology in a sex-specific manner and that these signals present different impacts on the liver depending on where in the intestinal compartment they originate. Hence, we aimed to uncover sex-related differences in the microbiome makeup of the small and large intestines and to pinpoint functional characteristics that may explain the mechanisms underlying MASLD biological processes.

MATERIALS AND METHODS

Experimental model

Male and female spontaneously hypertensive rats (SHR) and the Wistar-Kyoto (WKY) control strain from Charles River Laboratories in Wilmington, Massachusetts, were used in this study. The animals were housed in a controlled environment with a temperature of 24±1 and a 12-hour light-dark cycle. After a week of acclimatisation, the rats were randomly divided into two experimental groups, regardless of the strain. The groups were formed based on similar body weights and lengths at four weeks of age. One group was fed a standard chow diet (SCD) for 13 weeks starting from week 17. This group served as the control group (SHR, n=12 per sex; WKY, n=12 per sex), with food intake restricted to the baseline levels. The alternate group was given unrestricted access to a high-fat solid diet (HFD) consisting of 40% w/w bovine and porcine fats added to standard chow, as previously described [29]. Supporting information provides complete details of the experimental model, biochemical determinations, histological analysis of the liver tissue, and measurement of liver triglyceride content.

Microbiota composition (16S ribosomal RNA gene sequencing) in two distant gut compartments: sequence data analysis and operational taxonomy unit (OTU) clustering

The microbiota composition of male and female rats with MASLD and control animals was analysed using 16S rRNA gene sequencing. DNA was extracted from fresh-frozen intestinal samples, including the small intestine and descending colon. Intestinal segments, approximately 1.5 cm in length, were emptied of the luminal contents and gently washed with PBS (10 mM NaH2PO3, pH 7.4, 0.9% NaCl). DNA was extracted from tissues using a manual protocol outlined in our previous study, which consisted of two mechanical lysis steps [13]. The Supporting file contains comprehensive details.

Taxonomic and bioinformatic analyses

Subsequently, a stepwise analysis workflow was implemented, comprising data processing, visual exploration of rarefaction curves, community profiling, and clustering and correlation network and pattern searches. The workflow involves filtering, dereplication, sample inference, chimera identification, and merging of paired-end reads [30]. The Greengenes database (13.8) [31] was used for taxonomic annotations. The Supporting file contains comprehensive details.

Statistical analysis

The supporting information file provides full details on the analysis of complex metadata, including single and multivariate analyses, general linear models in the MaAsLin2 R package, linear and nonlinear microbial correlations, Sparse Estimation of Correlations among microbiomes (SECOM), LEfSe (linear discriminant analysis Effect Size), and linear discriminant analysis (LDA) score. The false discovery rate (FDR) was integrated to correct all gathered data for multiple tests, with statistical significance set at P<0.05. Analyses were conducted using the bioinformatics pipeline provided by the online platform Microbiome Analyst version 2.0 (https://www.microbiomeanalyst.ca/MicrobiomeAnalyst/) [32]. The Supporting information file contains comprehensive details.

Functional prediction profiling

The Supporting information file contains comprehensive details.

Liver immunohistochemistry (IHQ) for staining of lipopolysaccharides (LPS) and Toll-like receptor (Tlr4)

IHC was used to explore the abundance and localisation of LPS utilising an antibody specific to the Lipid A endotoxin region of LPS from Escherichia coli, as previously described [13]. To assess the liver protein levels of Tlr4 we used a specific antibody (OASG07216; Aviva Systems Biology, San Diego, Ca, USA). Additional information is available in the Supporting Information file.

RESULTS

Phenotypic findings and experimental model

Following dietary intervention, irrespective of the strain, both female and male rats developed microvesicular and macrovesicular hepatic steatosis (Supplementary Fig. 1A, B). SHR exhibited markedly higher scores of portal inflammation compared to the WKY strain (ordinal logistic regression: coef: 2.32±0.47, P=0.00000072). There were significant differences in lobular inflammation scores between male and female animals (P=0.031) (Table 1). Rats with metabolic syndrome traits such as heightened blood pressure and insulin resistance were more prone to develop visceral fat (Table 1). Serum triglyceride levels were considerably higher in the HFD groups (WKY rats: 211.7±18.2 and SHR: 216.6±19.8 mg/dL, respectively) compared to SCD-controls (WKY rats 88.5±19.4 and SHR 153.3±19.0 mg/dL, respectively); P=0.0000036. The changes in body weight over time, stratified by gender and strain, are presented in Supplementary Figure 1C, D. In addition, HFD was associated with a significant increase in visceral fat (either absolute mass or relative to body weight), irrespective of rat strain and sex. However, there were substantial differences between rat strains and sex, i.e., male and female SHR animals had significantly higher visceral fat mass than male and female WKY animals, particularly after HFD feeding. On the other hand, female animals had significantly more visceral fat relative to body weight than male animals. In terms of hepatic triglyceride content, the amount was significantly higher in the HFD groups (WKY rats 21.2±2.3 and SHR 21.4±2.5 μg/mg liver, respectively) compared to SCD controls (WKY rats 9.8±2.4 and SHR 12.3±2.4 μg/mg liver, respectively); P=0.0001. Table 1 presents sex-disaggregated data on biochemical, histological, and metabolic features. In this model, the animals do not develop liver fibrosis. This is a relevant consideration, as the development of liver fibrosis in rats necessitates the introduction of dietary manipulation or other interventions that may alter the microbiota, thereby rendering the analysis more complex and less reflective of human conditions.

Hierarchical taxonomic structure of the jejunum and descending colon in the disease state

The hierarchical structures of taxonomic features in MASLD and control samples in the jejunum and descending colon were compared using heat tree analysis (Fig. 1A, B).
Analysis of jejunum samples from rats with MASLD in comparison to control animals at the genus level indicate an increase in the abundance ratios of Proteobacteria (Gammaproteobacteria, Alphaproteobacteria, Betaproteobacteria and Epsilonproteobacteria), Actinobacteria, Acidobacteria and a decrease in the abundance ratios of Turicibacteriales, among other taxa (Fig. 1A). Examination of samples extracted from the descending colon of animals that developed MASLD indicates a significant increase in the abundance ratio of Vivrionales, Verrucomicrobiae, and Actinobacteria and a notable decline in the abundance ratios of Bacteroidetes (see Fig. 1B).
Supplementary Figure 2A, B illustrates the taxonomic features of jejunum samples from rats that developed liver steatosis compared with those that did not, according to the rat strain. The results demonstrate that animals with liver steatosis and features of metabolic syndrome (SHR rats) exhibit, among many other taxa, an increase in Gammaproteobacteria, particularly Xanthomonadales, Alphaproteobacteria, and Actinobacteria (Bifidobacterium). The control strain (WKY rats) shows changes to a lesser extent. Supplementary Figure 2C illustrates representative taxa abundance according to rat strain in MASLD and control animals showing that in the case of Prevotella, changes are in the opposite direction.
The taxonomic features illustrated in Supplementary Figure 3A, B compare the microbiota of the descending colon samples from rats, according to the rat strain, that developed liver steatosis with those from rats that did not. SHR and WKY with MASLD exhibit a marked reduction in the amount of the bacterial genus Prevotella. Nevertheless, as illustrated in Supplementary Figure 3A, B, WKY rats exhibit a disparate taxonomic profile, particularly with regard to the relative abundance of taxa expressed as median ratio (Log2) rather than the presence of a given taxon. Supplementary Figure 3C provides an illustrative example of the deregulated taxa in MASLD compared to the control animals in the descending colon samples.

The microbial composition and structure of the small and large intestines exhibit sex-related characteristics

As a primary objective, we analysed the composition of the intestinal microbiota in male and female rats. The results showed significant differences in the community profiles of females and males in the small intestine. While jejunum samples from female rats showed substantially higher alpha diversity (Fig. 2A), richness in the descending colon did not account for significant differences between the sexes (Fig. 2B).
Furthermore, we conducted PERMANOVA to examine the diversity of intestinal microbial communities between male and female animals. Analysis of beta diversity using the Bray-Curtis index highlighted significant gender-associated differences in the microbial composition of both the small and large intestines (Fig. 2C, D). Compared with male rats, female rats demonstrated increased beta diversity in the jejunum and colon microbiome (P=0.001).
The hierarchical structure of taxonomic features in the jejunum and descending colon stratified according to sex was compared using heat tree analysis, as shown in Figure 3A, B, respectively.

Network correlation analysis demonstrates sex-associated characteristics across regions of the intestinal microbiome

Correlation analysis was conducted to identify biologically significant associations between taxa and sex. To estimate the linear and nonlinear relationships between the bacterial taxa, we generated a microbiome interaction network for the small and large intestines using the SECOM approach. This approach accounts for both sample- and taxon-specific biases while maintaining sparsity. We identified significant positive correlations among the taxa, with increased abundance in both the small and large intestines of female rats. Additionally, we observed positive correlations between taxa enriched in both the jejunum and descending colon of male rats. In contrast, a negative correlation was observed between taxa that were more abundant in the female intestinal microbiome and those that were more abundant in the male intestinal microbiome (Supplementary Fig. 4), irrespective of the sample location. For example, the orders Erysipelotrichales, Deferribacteres, and Chlamydiales, which were enriched in the jejunum of female rats, were negatively correlated with the orders Nitrospirales and Rickettsiales which were enriched in the jejunum of male rats (Supplementary Fig. 4). Conversely, the orders Brachispirales and Deferribacteres, which were abundant in the descending colon of female rats, were negatively correlated with the orders Turicibacteriales, Campylobacterales and Actinomycetales, which were abundant in the colon samples of male rats (Supplementary Fig. 4). Additionally, we employed Spearman’s correlation analysis to rank relationships between pairs, which yielded the same outcome, indicating a significant difference between the sexes.

Proximal small intestine (jejunum) microbiota profiling: Core taxonomic features and analysis stratified according to disease state and sex

The core taxonomic heatmap across jejunum samples derived from female and male rats is shown in Supplementary Figure 5 panel I A, B. At the family taxa level, jejunum microbiome profiling in female rats showed 13 most abundant features at a sample prevalence higher than 20%, including Clostridiaceae (100%), Enterobacteriaceae (98%), Lactobacillaceae (96%), Ruminococcaceae (94%), Helicobacteraceae (89%), Bifidobacteriaceae (79%), Erysipelotrichaceae (75%), Alcaligenaceae (61%), Bacteroidaceae (59%), Verrucomicrobiaceae (38%), Lachnospiraceae (34%), Turicibacteraceae (32%), and Prevotellaceae (24%). Supplementary Figure 5A (panels I and II) presents further detail. In male rats, jejunal microbiome profiling revealed that the most abundant taxa were Lactobacillaceae and Clostridiaceae, present in all samples. Additionally, Ruminococcaceae was found in 93% of the studied samples, Helicobacteraceae in 86%, Enterobacteriaceae in 71%, Bifidobacteriaceae in 53%, Turicibacteraceae in 51%, Erysipelotrichaceae in 42%, Thermodesulfovibrionaceae in 28%, Bacteroidaceae in 24%, and Verrucomicrobiaceae in 22%.
The analysis focused on the liver steatosis variable (MASLD vs. control animals) after adjusting for sex and showed a significant increase at the class level for Epsilonproteobacteria (logarithm of fold change ratios [Log2FC]: 1.32, FDR P-value: 0.005, Wilcoxon Rank Sum test), Alphaproteobacteria (1.0, P=0.029), and Actinobacteria (0.624, P=0.038) in animal samples that developed MASLD versus control animals. At the order level, five significant features associated with MASLD were identified after adjusting for sex. These included an increase in the abundance of Campylobacterales (1.31, P=0.005), Streptophyta (1.31, P=0.013), Rickettsiales (1.63, P=0.025), and Chlamydiales (0.671, P=0.043), as well as a decrease in the abundance of Ellin 6513 (–0.522, P=0.025). At the family level, significant changes were identified in the abundance of the four taxa in the MASLD rats. Specifically, an increase was observed in Helicobacteraceae (1.31, P=0.0045) and Rhabdochlamydiaceae (0.671, P=0.049), as well as changes in the abundance of Paraprevotellaceae (–0.845, P=0.034) and Aerococcaceae (–0.669, P=0.04).
Subsequently, we conducted an analysis using sex as the main variable, adjusted for the presence of MASLD (liver steatosis) (Supplementary Table 1). Taxonomic analysis at the genus level identified 52 significant features associated with sex after the MASLD adjustment (Supplementary Table 1). For example, the most remarkable changes occurred in the Mucispirillum (Log2FC: 3.23), Bradyrhizobium (Log2FC: 3.11), Corynebacterium (Log2FC: 2.0), Streptococcus (Log2FC: 1.85), and Escherichia (Log2FC: 1.78) taxa, which were significantly increased in the jejunum samples of female rats compared to their male counterparts (see the complete list in Supplementary Table 1). In contrast, the number of Lardizabala (Log2FC: –3.14), Gemella (Log2FC: –1.28), and Streptomyces (Log2FC: –1.06), along with various other taxa, showed a considerable increase in the jejunum samples of male rats.
Furthermore, we utilised LDA to identify the taxa that were most likely responsible for the differences between the respective phenotypes and biological conditions of interest, as determined by LDA scores. Using LEfSe approach we discovered that 24 significant taxon features at the genus level were strongly linked to MASLD as a dichotomous trait (Supplementary Fig. 6A). Analysis of the relative abundance of features in samples from control animals compared to animals that developed MASLD revealed that three taxa, Aggregatibacter, Turicibacter and Gemella were significantly decreased in animals with MASLD. Additionally, 21 features, including Escherichia, Pseudomonas, and Bifidobacterium among other relevant taxa, were significantly increased in animals with MASLD (Supplementary Fig. 6A). Finally, after adjusting for sex, LEfSe analysis revealed 40 significant taxon features at the genus level associated with MASLD (see Supplementary Fig. 7). LDA scores for the top 15 features are shown in Figure 4A.
Supplementary Figure 8 shows the abundance profiles between animals with MASLD and the control group according to the respective sex in a quantitative (using the median abundance) and statistical manner (using the nonparametric Wilcoxon Rank Sum test) in the jejunum, along with some representative taxa abundance. For example, the Clostridia class demonstrated an increase in MASLD males, but not in females. Conversely, the Erysipelotrichaceae exhibited a significant increase only in female animals with MASLD.

Large intestine (descending colon) microbiota profiling: Core taxonomic features and analysis stratified according to disease state and sex

The core taxonomic heatmaps for the samples obtained from the descending colon of female and male rats are shown in Supplementary Figure 5 (panels I and II, C, D). At the family taxa level, profiling of the female rat large intestine microbiome revealed 21 of the most prevalent characteristics, with a sample relative abundance greater than 20%. Helicobacteraceae (100%), Ruminococcaceae (96%), Deferribacteraceae (92%), Alcaligenaceae (84%), and Clostridiaceae (77%) were among the key families. Bifidobacteriaceae (73%), Enterobacteriaceae (71%), Bacteroidaceae (67%), Desulfovibrionaceae (61%), Brachyspiraceae (59%), Lachnospiraceae (57%), Veillonellaceae (53%), Paraprevotellaceae (53%), and Erysipelotrichaceae (49%) also played significant roles (Supplementary Fig. 5C, panels I and II). In contrast, the descending colon of male animals contained 17 prevalent taxa at a rate higher than 20%. These included Helicobacteraceae (100%), Ruminococcaceae (95%), Enterobacteriaceae (87%), Clostridiaceae (82%), Erysipelotrichaceae (76%), Lactobacillaceae (73%), Veillonellaceae (69%), Turicibacteraceae (58%), Paraprevotellaceae (54%), and Prevotellaceae (48%) (Supplementary Fig. 5D panels I and II).
Further, we conducted a statistical comparison of taxon abundance using a multiple linear regression analysis with covariate adjustment. First, we examined the liver steatosis variable (MASLD vs. control animals), which was adjusted for sex. We discovered a significant increase in Deferribacteres at the class level (log 2FC: 1.13, FDR: P=0.0291) in animals developing MASLD compared with non-MASLD animals. At the family level in MASLD rats, we observed a noteworthy increase in the proportion of four types, which encompassed Vibrionaceae (log 2FC: 1.74, FDR: P=0.0034), Deferribacteraceae (log 2FC: 1.12, FDR: P=0.03), and Aerococcaceae (log 2FC: 0.91, FDR: P=0.033), in conjunction with Corynebacteriaceae (log 2FC:1.56, FDR: P=0.001). Conversely, we detected a significant decrease in the abundance of Prevotellaceae (log 2FC: –2.18, FDR: P=0.0036) and Paraprevotellaceae (log 2FC: –1.75, FDR: P=0.02). Second, using LEfSe, we identified 13 genus-level taxon features significantly linked to MASLD, as shown in Supplementary Figure 6B. Analysis of the relative abundance in the control animals revealed that nine taxa were significantly increased in animals with MASLD. These taxa included Mucispirillum, Catenibacterium, Streptococcus, Sulfurimonas, Vibrio, Anaerobaculum, Bifidobacterium, Faecalibacterium, Acinetobacter and Desulfovibrio. In contrast, three genera showed significant decreases, including Prevotella, CF231 and SMB53.
Additionally, we analysed the sex variable (female versus male) adjusted for MASLD as our primary data. Analysis at the genus level revealed 26 significant characteristics associated with sex adjusted by MASLD (Supplementary Table 2). Finally, we identified 31 taxonomic features at the genus level that were significantly associated with both MASLD and sex (Supplementary Figure 9). The LDA scores for the top 15 features are shown in Figure 4B.
Supplementary Figure 10A, B illustrates the genus-level taxon features of the LEfSe that were significantly correlated with MASLD in the two intestinal compartments, the jejunum samples (a) and the descending colon (b), stratified according to the rat strain (WKY and SHR).
Supplementary Figure 11 illustrates the abundance profiles of animals with MASLD and the control group, stratified by sex, in a quantitative and statistical manner. The abundance profiles are presented in descending colon and include representative taxa abundance graphs. The quantitative analysis employs the median abundance, while the statistical analysis employs the non-parametric Wilcoxon Rank Sum test. For instance, the Desulfovibrionales increased in MASLD females but not in males. Furthermore, although Escherichia was increased in MASLD regardless of sex, the abundance in male animals with MASLD was significantly higher.

Mechanistic insights

LPS staining score is much greater in male rat livers with MASLD than in females

The outer membrane of most Gram-negative bacteria is composed of lipopolysaccharides (LPS) in the outer leaflet. LPS, also known as an endotoxin, exhibits significant biological activity. To shed light on possible explanations for the observed sex-specific gut microbiome findings in rats with MASLD, we examined LPS immunoreactivity in the liver tissue from a subset of animals (n=50). We hypothesised that the distinct gut microbiome profiles of males and females may affect the biology of MASLD. LPS levels in the livers of animals with MASLD (n=34, 1.41±1.03) were significantly higher than those in the control group (n=16, 0.21±0.31), P≤0.00001, mean±SD, Mann–Whitney test. Most importantly, significantly higher levels of LPS were detected in the livers of male rats (n=15, 2.23±0.85) with MASLD compared to their female counterparts (n=19, 0.84±0.78); P=0.0004. There were no discernible differences between the strains. In control animals, there were no differences between sexes (female control, n=7, 0.28±0.39 versus male control n=9, 0.16±0.25; P=0.68). LPS was detected in the parenchymal regions that were situated near the central vein, in zone 3, and within the portal areas (Fig. 5AF). Figure 5 panels E, F illustrate the presence of LPS staining in male animals that developed MASLD in liver lobular areas outside the central vein region and the portal triad.

Liver levels of Tlr4 are significantly increased in male animals with MASLD

The downstream effects of endotoxin translocation may include the induction of toll-like receptors (TLR) in the liver, resulting in the activation of transcription factors that induce an inflammatory response. LPS activates inflammatory signalling pathways, mainly through the classic Toll-like receptor 4 (TLR4, Tlr4 in rodents) on the cell surface, resulting in the production of inflammatory factors. To explore differences in Tlr4 expression in female and male animals with MASLD, hepatic expression levels were investigated using IHQ (Fig. 5GL). Consistent with the results of LPS expression in liver samples, we observed significantly higher levels of Tlr4 in the livers of male animals with MASLD (1.4±0.96) compared to their female counterparts (0.41±0.34), P=0.05 Mann–Whitney test.

Microbial profiling reveals distinct predicted sex-specific and disease-specific functional signatures across gut anatomical compartments

We analysed the significant KEGG pathways associated with the tissue microbiome in the proximal small intestine (jejunum) (Fig. 6) and the descending colon (Fig. 7).
Analysis of the predicted pathways in the jejunum revealed 27 metabolic pathways, seven pathways related to ABC transporters, six pathways related to the biosynthesis of secondary metabolites, four pathways related to the biosynthesis of cofactors, two pathways related to cancer, and one pathway related to fatty acid biosynthesis, among many other significant pathways with potential implications for human health (Supplementary Table 3).
Examination of the predicted pathways in the descending colon identified 12 metabolic pathways and 5 pathways associated with the biosynthesis of secondary metabolites, as well as other relevant pathways (Supplementary Table 4).
We then performed sex-stratified analysis in each intestinal compartment. Analysis of notable pathways predicted in the jejunum of female rats revealed the presence of KEGG pathway K13541 (cobalt-precorrin 5A hydrolase), which is part of the biosynthetic pathway for cobalamin (vitamin B12). We also identified the K14468 pathway, which includes malonyl-CoA reductase and 3-hydroxypropionate dehydrogenase (NADP+), which are involved in propanoate metabolism.
KEGG pathway K03098 (APOD; a protein belonging to the apolipoprotein D and lipocalin families), which may be involved in phospholipid binding, arachidonic acid transport and modulation of eicosanoid production and release, was of particular interest in the examination of significant pathways in the male rat jejunum. Similarly, the KEGG pathway K13623 (btaB; S-adenosylmethionine-diacylgycerolhomoserine N-methyltransferase) was identified, which is associated with glycerophospholipid metabolism. Figure 6 shows the complete results.
Among the significantly associated pathways in the descending colon of female rats, we highlighted K08153 (MFS-major facilitator superfamily transporter, DHA1 family, multidrug resistance protein) (Fig. 7). This pathway is associated with signalling, cellular processes and drug efflux transporters. Antibiotics may have different effects on the gut microbiota in men and women, and this phenomenon may be an important reason for this.
In male rats, we focused on a pathway related to pyruvate metabolism, specifically, the K00114 pathway (alcohol dehydrogenase (cytochrome c) [EC:1.1.2.8]) (Fig. 7). This pathway has a wide spectrum of effects on primary and secondary alcohols and has an additional function in ethanol synthesis. The results are presented in Figure 6.
The Supplementary Figures 12, 13 illustrate the predicted KEGG pathways in the proximal small intestine (jejunum) and descending colon, respectively, stratified by disease (MASLD vs. controls) and sex. It is noteworthy that there are differences in the predicted functionality among sexes. For example, KO KEGG terms of functional orthologs predicted from the microbiota of female and male animals with and without MASLD denote common molecular networks associated with glycerolipids, as well as some distinctive pathways among them (see the complete list of pathways in Supplementary Tables 58).

DISCUSSION

This study used an experimental MASLD model to identify sex differences in the microbiome of both the small and large intestines. To ascertain whether the differences are potentially linked to alterations in the microbiome-derived hepatic inflammatory signals, we investigated the hepatic expression of Gram-negative-derived LPS and Tlr4.
We observed that animals that developed MASLD showed a high proportion of Proteobacteria, particularly Enterobacteria, Actinobacteria and Acidobacteria in their jejunal samples, compared to the control group. In contrast, animals that developed MASLD showed a significant increase in the abundance of Vivrionales, Actinobacteria, and Deferribacterias in the samples of the descending colon. Importantly, sex-linked differences were found in the gut microbiota, particularly in relation to the overall microbiota composition, taxonomic structure, and abundance between the small and large intestines. In jejunal samples, female animals had a higher proportion of Erysipelotrichales, Deferribacteres, and Chlamydiales than male animals. Conversely, in samples from the descending colon, female animals showed a higher proportion of Brachispirales and Deferribacteres than other taxa. Furthermore, compared with males, female jejunum samples exhibited higher overall community heterogeneity, as measured by alpha diversity. However, there was no substantial increase in overall community heterogeneity in female colon samples. Beta diversity, which quantifies similarities and differences between communities (samples), showed pronounced differences in both female jejunum and colon samples. Correlation and network analyses have confirmed significant relationships between species and sex, which hold biological significance and possibly explain interindividual sex-specific phenotypic differences.
The distribution of LPS immunoreactivity in the liver samples from male and female rats with MASLD differed, suggesting that the gut microbiome profile may have sex-specific effects on MASLD biology, particularly with respect to enterobacteria-derived endotoxins. This finding is consistent with the observed differences in Tlr4 expression levels in the livers of male and female animals. Differences in the microbiome profiles of colon samples may explain these results. For instance, although the genus Escherichia is present in colon samples of both female and male animals, it is more abundant in males. Additionally, female animals challenged with HFD developed higher liver lobular inflammation scores, which could be explained by the high prevalence of Mucispirillum in the large intestine microbiome of female rats. Mucispirillum spp. belong to the phylum Deferribacteres and are commonly found in the microbiota of rodents, pigs, and humans, although at low abundance [33]. This taxon has been observed to increase during inflammation and has been suggested to be a commensal dwelling in mucus that can cause disease [34].
It is important to note that these descriptive observations are not intended to infer cause-and-effect relationships. On the contrary, the findings can be used to potentially explain the mechanisms behind the influence of different taxa on the liver phenotype.
This study also found gut functional signatures that differed between the sexes. The microbiomes of jejunum and colon samples from female and male animals produced predicted functional signatures, suggesting that sexual dimorphism influences the phenotype by interacting with host metabolism, particularly hepatic lipid synthesis and inflammatory pathways. For example, the microbial functional profiles of jejunum samples from female and male animals showed high scores for pathways related to propanoate metabolism and vitamin B12 biosynthesis, respectively. Additionally, there was increased activity of bacteria involved in arachidonic acid transport in male samples. The predicted functionality of the bacterial communities in samples from the female colon revealed significant pathways related to various signalling and cellular processes, including drug efflux transporters. In contrast, the bacterial profile in the colon samples from male animals showed a highly ranked pathway associated with pyruvate metabolism, which could indicate a higher likelihood of producing secondary alcohols owing to the pathway associated with alcohol dehydrogenase. These findings enhance our understanding of sex-related differences in MASLD biology.

Strengths and limitations

Ethical considerations preclude the use of human samples in the validation of our hypothesis. Therefore, an experimental model of steatotic liver disease that mimics human MASLD was employed to analyse the microbiome of the upper small intestine and colon. The main challenge is the translation of preclinical results to complex human populations and the intricacies associated with human diseases. A notable feature of our investigation is the use of an experimental model that conforms to the recently established diagnostic criteria for MASLD [1]. Because metabolic syndrome and MASLD are complex conditions that involve both environmental and genetic factors, finding suitable experimental models to study them is challenging. Meeting the current diagnostic criteria for MASLD, including liver fat accumulation, metabolic dysregulation, and cardiovascular risk factors, requires careful attention. However, it is worth noting that the SHR strain has a genetic predisposition to a range of metabolic syndrome features, such as hypertension, glucose intolerance, and dyslipidemia, despite the absence of overt obesity, the lack of which was compensated for by HFD. Nevertheless, after HFD challenge, SHR rats accumulated significantly higher levels of visceral fat.
Our findings demonstrate that distant anatomical regions of the gut have a unique microbiome profile, which is consistent with the results of previous studies [35-37]. Therefore, stool cannot be substituted by the entire gut microbiome. However, the observed heterogeneity in distant regions of the gut may affect the biology of MASLD, which largely depends on sex-specific patterns of microbial abundance. This is particularly important because microbiome-related studies on MASLD rarely test sex as the target variable of interest.
Finally, it can be argued that it is challenging to extrapolate conclusions from experimental studies to humans. Interestingly, we found that the most notable features observed in animals that developed hepatic steatosis in the metabolic syndrome-related model, such as Gammaproteobacteria, particularly Xanthomonadales, Alphaproteobacteria and Actinobacteria (Bifidobacterium), mirror the findings observed in humans [13].
In conclusion, our study offers novel insights into the pathogenic mechanisms of MASLD, which represents a pivotal initial step in translating knowledge to the clinic. In this context, we consider that the generation of new knowledge on the potential for heterogeneity in MASLD disease manifestations based on sexual differences in the composition of the gut microbiome represents one of the key steps in implementing personalised medicine and subsequently, its direct applicability to a clinical setting.

ACKNOWLEDGMENTS

Agencia Nacional de Promoción Científica y Tecnológica Argentina, FONCyT. Argentina. PICT 2018-889, PICT 2019-0528; PICT 2018-00620 and PICT 2020-SerieA-0799. CONICET, Argentina, PUE 0055.

FOOTNOTES

Authors’ contribution
All authors have read and approved the final version of the manuscript (CJP, MSL, MS, SIG, AS, and SS) read and approved the final version of the manuscript. CJP: Study concept and design, biological material collection, data acquisition, data analysis and interpretation, molecular studies, general study supervision, statistical analysis, functional prediction, manuscript drafting, project administration, and securing funding. MSL contributed to sample preparation and animal care, performed DNA extraction and purification, and biochemical determinations. MS contributed to the sample preparation and animal care. SIG, animal care; IHC, immunohistochemistry; AS, bioinformatics analysis of bacterial sequencing data and data processing and presentation. SS: Study concept and design, data acquisition, histological evaluation, molecular studies, data analysis and interpretation, functional prediction, general study supervision, project administration, manuscript drafting, and securing funding.
Conflicts of Interest
The authors have no conflicts to disclose.

SUPPLEMENTAL MATERIAL

Supplementary material is available at Clinical and Molecular Hepatology website (http://www.e-cmh.org).
Supporting information.
cmh-2024-0359-Supporting-information.pdf
Supplementary Figure 1.
Liver histology. The figure illustrates the liver histology of a representative animal from each experimental group, namely, the MASLD (A) and control groups (B). Hematoxylin and eosin (HE) staining of liver sections was performed at the end of the experiment on representative rats from each experimental group, as described in the Materials and Methods. Severe panlobular hepatic steatosis (micro-and macrovesicular steatosis) was observed in the high-fat diet group (panel A). The original magnification shown in the figures is 400X. CV, central vein; LD, lipid droplet; H, hepatocyte. Lower panels show body weight curves along the feeding period (first point basal condition and consequent weeks of control diet (CD) and high-fat diet feedings (TW 1 to the experiment end) in both strains (WKY and SHR) separated by sex (females, panel [C] and males, panel [D]).
cmh-2024-0359-Supplementary-Figure-1.pdf
Supplementary Figure 2.
Hierarchical taxonomic structure by disease and strain groups in the jejunum samples. A heat phylogenetic tree was constructed to demonstrate the hierarchical structure of taxonomic features in metabolic dysfunction-associated steatotic liver disease (MASLD) and control samples in the jejunum in Wistar-Kyoto (A) and spontaneously hypertensive rats (B). The heat phylogenetic tree analysis used the hierarchical structure of taxonomic classifications to show abundance profiles between animals with MASLD and the control group according to the respective strain in a quantitative (using the median abundance) and statistical manner (using the non-parametric Wilcoxon Rank Sum test). The figure illustrates taxonomic features at the genus level. In this taxonomic tree, each circle represents a taxon, and the lines show the hierarchical relationships between them. (C) Representative boxplot abundance by disease (MASLD vs. control) and strain (SHR-WKY) groups in the jejunum samples. P values stand for Mann-Whitney statistics.
cmh-2024-0359-Supplementary-Figure-2.pdf
Supplementary Figure 3.
Hierarchical taxonomic structure by disease and strain groups in the descending colon samples. A heat phylogenetic tree was constructed to demonstrate the hierarchical structure of taxonomic features in metabolic dysfunction-associated steatotic liver disease (MASLD) and control samples in the descending colon in Wistar-Kyoto (A) and spontaneously hypertensive rats (B). The heat phylogenetic tree analysis used the hierarchical structure of taxonomic classifications to show abundance profiles between animals with MASLD and the control group according to the respective strain in a quantitative (using the median abundance) and statistical manner (using the non-parametric Wilcoxon Rank Sum test). The figure illustrates taxonomic features at the genus level. In this taxonomic tree, each circle represents a taxon, and the lines show the hierarchical relationships between them. (C). Representative boxplot abundance by disease (MASLD vs. control) and strain (SHR-WKY) groups in the descending colon samples. P values stand for Mann-Whitney statistics.
cmh-2024-0359-Supplementary-Figure-3.pdf
Supplementary Figure 4.
Network correlation analysis. We conducted a correlation network analysis to determine pairwise correlations between taxonomic features in female and male animals in the jejunum (A) and descending colon (B). We used the SparCC correlation because it was specifically designed to address the issue of spurious correlations resulting from the compositional nature of microbiome data. The correlation network displays nodes that represent taxonomic features, and edges that represent correlations greater than the correlation threshold between pairs of taxa. The nodes are colored based on their abundance (represented by the size of the circle) by sex, and the edge sizes reflect the strength of the correlations between taxa. Positive correlations are highlighted in red, and negative correlations are highlighted in blue. A box plot comparing the abundance of significant taxa (arrows) between female and male animals appears at the bottom of the network, with the numerical values below showing the correlation coefficients between the node and its closest neighbors.
cmh-2024-0359-Supplementary-Figure-4.pdf
Supplementary Figure 5.
Comparisons of the core microbiome by sex. Panel I: Core heatmaps illustrating the core microbiome profiling of samples from the jejunum (A: female animals; B: male animals) and descending colon (C: female animals; D: male animals). The heatmap shows the relative abundances of the top bacterial genera (columns) in each taxon (rows). Hierarchical clustering is based on Ward’s clustering algorithm and Euclidean Distance measures to generate a hierarchical tree. Panel II: Abundance (raw data). The color bars indicate the relative abundance ranges.
cmh-2024-0359-Supplementary-Figure-5.pdf
Supplementary Figure 6.
Taxonomic features significantly associated with metabolic dysfunction-associated steatotic liver disease (MASLD). (A) Linear Discriminant Analysis Effect Size (LEfSe) on jejunal samples; (B) Linear Discriminant Analysis Effect Size (LEfSe) descending on colon samples. LEfSe was used to identify the features that explain differences between groups by using standard non-parametrical tests for statistical significance and additional tests that encode biological consistency and effect relevance. LEfSe used the Kruskal-Wallis test to identify taxa with significantly different relative abundances between groups. Taxa meeting the significance threshold are then analysed using LDA to estimate their effect size. The output is a ranked list of taxa based on their linear discriminant analysis (LDA) scores. A significance level of P<0.05 and an LDA score of 2 are commonly used to determine the taxa that best characterise each phenotype of interest, namely MASLD and control group. The analysis was conducted at the genus level.
cmh-2024-0359-Supplementary-Figure-6.pdf
Supplementary Figure 7.
Linear discriminant analysis Effect Size (LEfSe) analysis in jejunum samples associated with metabolic dysfunction-associated steatotic liver disease (MASLD) disaggregated by sex. LEfSe analysis was conducted to investigate the association between the MASLD score and sex. The analysis revealed 40 significant taxa features at the genus level associated with MASLD. M, male; F, female.
cmh-2024-0359-Supplementary-Figure-7.pdf
Supplementary Figure 8.
A hierarchical taxonomic structure, delineating the distribution of disease and sex groups within the jejunum samples. The heat phylogenetic tree analysis used the hierarchical structure of taxonomic classifications to show abundance profiles between animals with metabolic dysfunction-associated steatotic liver disease (MASLD) and the control group according to the respective sex in a quantitative (using the median abundance) and statistical manner (using the non-parametric Wilcoxon Rank Sum test). The figure illustrates taxonomic features at the genus level. In this taxonomic tree, each circle represents a taxon, and the lines show the hierarchical relationships between them. At the botton of the figure, boxpplots illustrate the most representative taxa. The box plots displayed at the bottom of both figures illustrate the relative abundance of some representative taxa. The P-values represent the results of Mann–Whitney statistical tests.
cmh-2024-0359-Supplementary-Figure-8.pdf
Supplementary Figure 9.
Linear discriminant analysis Effect Size (LEfSe) analysis in samples from the descending colon associated with metabolic dysfunction-associated steatotic liver disease (MASLD) disaggregated by sex. LEfSe analysis was conducted to investigate the association between the MASLD score and sex. The analysis revealed 31 significant taxon features at the genus level that were associated with MASLD. M, male; F, female.
cmh-2024-0359-Supplementary-Figure-9.pdf
Supplementary Figure 10.
Linear discriminant analysis Effect Size (LEfSe) analysis of significant taxa stratified by disease status (MASLD) and strain. The LEfSe procedure was used for linear discriminant analysis (LDA) at an adjusted false discovery rate (FDR/q-value <0.05). Significant taxa were ranked in decreasing order based on their LDA scores (x-axis). The mini-heat map on the right side of the plot indicates whether the number of taxa was higher (red) or lower (blue) in each group. (A) jejunum samples; (B) descending colon.
cmh-2024-0359-Supplementary-Figure-10.pdf
Supplementary Figure 11.
A hierarchical taxonomic structure, delineating the distribution of disease and sex groups within the samples of the descending colon. The heat phylogenetic tree analysis used the hierarchical structure of taxonomic classifications to show abundance profiles between animals with metabolic dysfunction-associated steatotic liver disease (MASLD) and the control group according to the respective sex in a quantitative (using the median abundance) and statistical manner (using the non-parametric Wilcoxon Rank Sum test). The figure illustrates taxonomic features at the genus level. In this taxonomic tree, each circle represents a taxon, and the lines show the hierarchical relationships between them. At the botton of the figure, boxpplots illustrate the most representative taxa. The box plots displayed at the bottom of both figures illustrate the relative abundance of some representative taxa. The P-values represent the results of Mann–Whitney statistical tests.
cmh-2024-0359-Supplementary-Figure-11.pdf
Supplementary Figure 12.
Predicted KEGG pathways in proximal small intestine (jejunum) stratified by disease (MASLD vs. controls) and sex. Description of KO (KEGG Orthology) names and ID numbers (https://www.genome.jp/kegg/ko.html) is provided in Supplementary Tables 5 and 6. KEGG, Kyoto Encyclopedia of Genes and Genomes; MASLD, metabolic dysfunction-associated steatotic liver disease.
cmh-2024-0359-Supplementary-Figure-12.pdf
Supplementary Figure 13.
Predicted KEGG pathways in desxcending colon samples stratified by disease (MASLD vs. controls) and sex. Description of KO (KEGG Orthology) names and ID numbers (https://www.genome.jp/kegg/ko.html) is provided in Supplementary Tables 7 and 8. KEGG, Kyoto Encyclopedia of Genes and Genomes; MASLD, metabolic dysfunction-associated steatotic liver disease.
cmh-2024-0359-Supplementary-Figure-13.pdf
Supplementary Table 1.
Jejunum samples: analysis using sex as the primary variable, adjusted for the presence of MASLD
cmh-2024-0359-Supplementary-Table-1.pdf
Supplementary Table 2.
Descending colon samples: analysis using sex as the primary variable, adjusted for the presence of MASLD
cmh-2024-0359-Supplementary-Table-2.pdf
Supplementary Table 3.
KEGG pathways associated with the tissue microbiome in the proximal small intestine (jejunum)
cmh-2024-0359-Supplementary-Table-3.pdf
Supplementary Table 4.
KEGG pathways associated with the tissue microbiome in the descending colon
cmh-2024-0359-Supplementary-Table-4.pdf
Supplementary Table 5.
KEGG pathways associated with the tissue microbiome in the proximal small intestine (jejunum): females MASLD vs. controls
cmh-2024-0359-Supplementary-Table-5.pdf
Supplementary Table 6.
KEGG pathways associated with the tissue microbiome in the proximal small intestine (jejunum): male MASLD vs. controls
cmh-2024-0359-Supplementary-Table-6.pdf
Supplementary Table 7.
KEGG pathways associated with the tissue microbiome in the descending colon: female MASLD vs. controls
cmh-2024-0359-Supplementary-Table-7.pdf
Supplementary Table 8.
KEGG pathways associated with the tissue microbiome in the descending colon: male MASLD vs. controls
cmh-2024-0359-Supplementary-Table-8.pdf

Figure 1.
Hierarchical taxonomic structure by disease group. A heat phylogenetic tree was constructed to demonstrate the hierarchical structure of taxonomic features in MASLD and control samples in the jejunum (A) and the descending colon (B). The heat phylogenetic tree analysis used the hierarchical structure of taxonomic classifications to show abundance profiles between animals with MASLD and the control group in a quantitative (using the median abundance) and statistical manner (using the nonparametric Wilcoxon Rank Sum test). The figure illustrates taxonomic features at the genus level. In this taxonomic tree, each circle represents a taxon and the lines show the hierarchical relationships between them. MASLD, metabolic dysfunction-associated steatotic liver disease.

cmh-2024-0359f1.jpg
Figure 2.
Taxonomic diversity profiling by sex. The plots illustrate variations in the community profiles of females and males in the small and descending intestines. Alpha diversity was assessed in samples from the jejunum (A) and descending colon (B) using the Chao1 nonparametric method to estimate the community species richness. Chao1 was used as an estimator of abundance-based bacterial richness. We used the Wilcoxon rank-sum test to assess the differences in diversity between males and females. The Bray-Curtis algorithm was used to calculate beta diversity, which measures the differences in community composition between samples from the jejunum (C) and colon (D). To test how much of the inter-individual microbial variation (Bray-Curtis and Jaccard distances) could be explained by sex, we performed permutational multivariate analysis of variance (PERMANOVA) using the adonis function. The P-value was determined using 1,000 permutations, and differences were considered significant at P<0.05. To aid in pattern identification and to gain biological insight, samples displayed on the PCoA were color-coded based on metadata (pink for female animals and light blue for male animals).

cmh-2024-0359f2.jpg
Figure 3.
Hierarchical taxonomic structure by sex. A heat phylogenetic tree was constructed to demonstrate the hierarchical structure of taxonomic features in female and male animals in the jejunum (A) and the descending colon (B). The heat phylogenetic tree analysis uses the hierarchical structure of taxonomic classifications to show abundance profiles in a quantitative (using the median abundance) and statistical manner (using the nonparametric Wilcoxon rank-sum test). The figure illustrates taxonomic features at the genus level. In this taxonomic tree, each circle represents a taxon and the lines show the hierarchical relationships between them.

cmh-2024-0359f3.jpg
Figure 4.
Dot plot representing significantly differential genera of the gut microbiome in MASLD stratified by sex. A dot plot is presented, showing the genera of the gut microbiome that were significantly different in MASLD stratified by sex. The LEfSe procedure was used for linear discriminant analysis (LDA) at an adjusted false discovery rate (FDR/q-value < 0.05). Significant taxa were ranked in decreasing order based on their LDA scores (x-axis). The mini-heat map on the right side of the plot indicates whether the number of taxa was higher (red/brown) or lower (blue/violet) in each group. (A) jejunum samples; (B) descending colon. MASLD, metabolic dysfunction-associated steatotic liver disease.

cmh-2024-0359f4.jpg
Figure 5.
Liver lipopolysaccharides (LPS) and Tlr4 staining. LPS (A–F) and toll-like receptor 4 (Tlr4) (G–L) protein expression in liver tissue samples from male and female animals with MASLD and controls were detected using immunohistochemistry. Representative samples are shown at the original magnification of ×400. MASLD, metabolic dysfunction-associated steatotic liver disease; LD, lipid droplet; BH, ballooned hepatocytes; CV, central vein; H, hepatocytes.

cmh-2024-0359f5.jpg
Figure 6.
Predicted Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways in proximal small intestine (jejunum) by sex. The KEGG pathways were significantly different between the two groups (female and male animals). The bars on the left show the abundance (mean proportion, %) of different functional classifications in the two groups. The dots on the right side show the differences in the mean proportions (%) within the 95% confidence interval between the two groups. The rightmost values indicate Benjamini-Hochberg-adjusted P values. Phylogenetic Investigation of Communities by Reconstruction of Unobserved States 2 (PICRUSt2) analysis resulted in KEGG. Statistical analysis was performed using the STAMP software. The figure was divided into two panels for readability.

cmh-2024-0359f6.jpg
Figure 7.
Predicted Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways in the descending colon by sex. The KEGG pathways were significantly different between the two groups (female and male animals). The bars on the left show the abundance (mean proportion, %) of different functional classifications in the two groups. The dots in the right show the differences in the mean proportions (%) within the 95% confidence interval between the two groups. The rightmost values indicate Benjamini-Hochberg-adjusted P-values. Phylogenetic Investigation of Communities by Reconstruction of Unobserved States 2 (PICRUSt2) analysis resulted in KEGG. Statistical analysis was performed using the STAMP software.

cmh-2024-0359f7.jpg

cmh-2024-0359f8.jpg
Table 1.
Sex-disaggregated data on biochemical, histological, and metabolic features
Variable Males
Females
P-value (ANOVA)
WKY SHR WKY SHR Sex Strain Diet
n=12/group SCD HFD SCD HFD SCD HFD SCD HFD
 SBP mmHg 124.19±11 132.28±15 213.88±20.63 216.92±28 116.88±9.57 117.18±8.14 203.56±10 199.75±20 0.0003 0.0001 NS
 Body weight (BW), g 432.33±33 429.27±35 482.7±29.99 457.1±44 212.83±8.9 221.25±9.5 243.86±17 295±43 0.0001 0.0001 NS
 Liver weight (LW), g 13.65±1.4 15.99±1.6 21.51±1.8 17.77±3.24 7.64±0.63 8.18±0.49 11.2±1.42 12.52±2.2 0.0001 0.0001 NS
 VFW, g 7.27±1.2 12.96±3.1 9.52±2.72 19.88±4.5 4.7±1.2 8.28±1.3 3.5±1.01 15.53±5.5 0.0001 0.0001 0.0001
 LW/BW 0.032±0.002 0.037±0.003 0.045±0.003 0.039±0.004 0.036±0.002 0.037±0.002 0.046±0.004 0.042±0.004 0.0005 0.0001 NS
 VFW/BW 0.017±0.003 0.028±0.009 0.02±0.005 0.043±0.007 0.02±0.01 0.037±0.005 0.014±0.004 0.052±0.013 0.003 0.0001 0.0001
  Glycemia, mg/dL 127.83±22 144.07±21 122.4±19 120.7±23 122.5±23.07 117.92±18 127.71±17 149.75±47 NS NS NS
  Total Chol, g/dL 74±5.2 68±7.2 96.7±8.2 86.5±9.6 89.17±17 87.08±9.6 93.5±9.1 88.08±15 0.0004 0.0001 0.009
  HDL Chol, mg/dL 29±2 32.4±2.9 28.1±1.29 27.7±3.9 37.08±3.7 42.25±5.4 33.07±3.3 34.75±4.4 0.0001 0.0001 0.002
 ALT (U/L) 55.27±16.95 62.17±16.26 53.6±9.92 74.7±12.88 70.42±28.01 71.08±11.11 47.08±10.98 79.21±31.79 NS NS 0.0003
 AP, IU/mL 231.58±48.21 425.2±116.18 322.1±66.47 602.2±144.18 259.27±50.62 498.17±118.45 243.5±61.27 428.08±141.38 NS 0.031 0.001
  Albumin, g/dL 3.23±0.2 3.65±0.13 3.45±0.18 3.53±0.29 3.79±0.42 3.91±0.2 3.64±0.17 3.7±0.28 0.0001 NS 0.001
  Insulin, ng/mL 5.74±3.7 4.1±2.82 7.95±4.61 6.96±4.2 1.43±1.4 1.32±0.95 3.51±2.32 4.19±1.82 0.0001 0.0001 NS
  HOMA 1.8±1.3 1.44±1.1 2.33±1.47 1.98±1.18 0.38±0.29 0.37±0.28 1.06±0.74 1.46±0.67 0.0001 0.0006 NS
 Serum TG, mg/dL 74.87±44 215.81±74 118.48±63 209.64±57 101.03±56. 206.06±16 178.13±88 222.34±14 NS NS 0.0001
 Liver TG* 0.01±0.005 0.025±0.023 0.014±0.008 0.025±0.013 0.009±0.004 0.017±0.011 0.011±0.004 0.018±0.009 0.060 NS 0.0001
 LDL Chol, mg/dL 30.3±13 7.53±16 44.9±15 16.87±16 31.88±14 4.15±33 24.81±24 8.87±33 NS 0.05 0.0001
Histological features
 Score steatosis 0.1±0.1 3.0±0.1 0.5±0.5 1.7±1.2 0.83±0.84 2.67±0.49 0.86±0.77 2.67±0.65 0.001 NS 0.0001
 % steatosis 0.5±1.24 93.6±8.91 5.5±4.72 41.4±39 15.42±18 77.92±20 20.36±20 70.83±25 0.01 0.01 0.0001
 Hepatocellular ballooning 0±0 0.4±0.51 0±0 0.2±0.42 0±0 0.33±0.49 0±0 0.42±0.67 NS NS 0.0001
 Lobular inflammation 0.25±0.62 0.47±0.52 0.3±0.48 0.7±0.82 0.67±0.99 0.75±0.97 0.71±0.83 0.92±0.52 0.031 NS NS
 Portal inflammation 0.25±0.45 0.2±0.41 0.9±0.57 0.7±0.48 0.17±0.39 0.33±0.49 1.07±0.73 1±0.95 NS 0.0001 NS
 Fibrosis score 0±0 0±0 0±0 0±0 0±0 0±0 0±0 0±0 - - -

Values are presented as mean±standard deviation.

SBP, systolic blood pressure; g, grams; VFW, visceral fat weight; TG, triglycerides; ALT, alanine aminotransferase; AP, alkaline phosphatase; Total Chol, total cholesterol; LDL Chol, LDL cholesterol; HFD, high-fat solid diet; SHR, spontaneously hypertensive rats; SCD, standard chow diet; WKY, Wistar-Kyoto; NS, not significant.

* Liver TG: Liver triglycerides (mg)/tissue (mg).

Abbreviations

FC
fold change
FDR
False discovery rate
HFD
high-fat solid diet
HOMA
homeostatic model assessment
IHQ
immunohistochemistry
LEfSe
Linear discriminant analysis Effect Size
LDA
linear discriminant analysis
LPS
lipopolysaccharides
MASLD
metabolic dysfunction-associated steatotic liver disease
NAFLD
non-alcoholic fatty liver disease
OTU
operational taxonomy unit
PCoA
principal coordinate analysis
PERMANOVA
permutational multivariate analysis of variances
PICRUST
Phylogenetic investigation of communities by reconstruction of unobserved states
TLR4
Tlr4
SECOM
Sparse Estimation of Correlations among Microbiomes
SHR
spontaneously hypertensive rats
SCD
standard chow diet
SBP
Systolic blood pressure
WKY
Wistar-Kyoto

REFERENCES

1. Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol 2023;79:1542-1556.
pmid
2. Brunt EM, Wong VW, Nobili V, Day CP, Sookoian S, Maher JJ, et al. Nonalcoholic fatty liver disease. Nat Rev Dis Primers 2015;1:15080.
crossref pmid pdf
3. Caussy C, Tripathi A, Humphrey G, Bassirian S, Singh S, Faulkner C, et al. A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease. Nat Commun 2019;10:1406.
crossref pmid pmc pdf
4. Mouzaki M, Comelli EM, Arendt BM, Bonengel J, Fung SK, Fischer SE, et al. Intestinal microbiota in patients with nonalcoholic fatty liver disease. Hepatology 2013;58:120-127.
crossref pmid
5. Boursier J, Mueller O, Barret M, Machado M, Fizanne L, Araujo-Perez F, et al. The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Hepatology 2016;63:764-775.
crossref pmid pmc pdf
6. Bajaj JS, Reddy KR, Tandon P, Garcia-Tsao G, Kamath PS, O’Leary JG, et al. Association of serum metabolites and gut microbiota at hospital admission with nosocomial infection development in patients with cirrhosis. Liver Transpl 2022;28:1831-1840.
crossref pmid pmc pdf
7. Philips CA, Schnabl B, Bajaj JS. Gut microbiome and alcohol-associated liver disease. J Clin Exp Hepatol 2022;12:1349-1359.
crossref pmid pmc
8. Saboo K, Petrakov NV, Shamsaddini A, Fagan A, Gavis EA, Sikaroodi M, et al. Stool microbiota are superior to saliva in distinguishing cirrhosis and hepatic encephalopathy using machine learning. J Hepatol 2022;76:600-607.
crossref pmid
9. Albhaisi SAM, Bajaj JS. The influence of the microbiome on NAFLD and NASH. Clin Liver Dis (Hoboken) 2021;17:15-18.
crossref pmid pmc pdf
10. Bajaj JS, Khoruts A. Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis. J Hepatol 2020;72:1003-1027.
crossref pmid
11. Hsu CL, Schnabl B. The gut-liver axis and gut microbiota in health and liver disease. Nat Rev Microbiol 2023;21:719-733.
crossref pmid pmc pdf
12. Tilg H, Adolph TE, Trauner M. Gut-liver axis: pathophysiological concepts and clinical implications. Cell Metab 2022;34:1700-1718.
crossref pmid
13. Sookoian S, Salatino A, Castaño GO, Landa MS, Fijalkowky C, Garaycoechea M, et al. Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease. Gut 2020;69:1483-1491.
crossref pmid
14. Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012;482:179-185.
crossref pmid pmc pdf
15. Tilg H, Adolph TE, Dudek M, Knolle P. Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity. Nat Metab 2021;3:1596-1607.
crossref pmid pdf
16. Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol 2016;14:e1002533.
crossref pmid pmc
17. Brown H, Esterházy D. Intestinal immune compartmentalization: implications of tissue specific determinants in health and disease. Mucosal Immunol 2021;14:1259-1270.
crossref pmid pdf
18. Ayonrinde OT, Olynyk JK, Beilin LJ, Mori TA, Pennell CE, de Klerk N, et al. Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease. Hepatology 2011;53:800-809.
crossref pmid
19. Burgueño AL, Cabrerizo R, Mansilla NG, Sookoian S, Pirola CJ. Maternal high-fat intake during pregnancy programs metabolic-syndrome-related phenotypes through liver mitochondrial DNA copy number and transcriptional activity of liver PPARGC1A. J Nutr Biochem 2013;24:6-13.
crossref pmid
20. Lonardo A, Nascimbeni F, Ballestri S, Fairweather D, Win S, Than TA, et al. Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps. Hepatology 2019;70:1457-1469.
crossref pmid pmc pdf
21. Yang JD, Abdelmalek MF, Pang H, Guy CD, Smith AD, Diehl AM, et al. Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis. Hepatology 2014;59:1406-1414.
crossref pmid pmc
22. Yang JD, Abdelmalek MF, Guy CD, Gill RM, Lavine JE, Yates K, et al. Patient sex, reproductive status, and synthetic hormone use associate with histologic severity of nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol 2017;15:127-131.e2.
pmid
23. Cherubini A, Ostadreza M, Jamialahmadi O, Pelusi S, Rrapaj E, Casirati E, et al. Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women. Nat Med 2023;29:2643-2655. Erratum in: Nat Med 2024;30:1212.

24. Burra P, Bizzaro D, Gonta A, Shalaby S, Gambato M, Morelli MC, et al. Clinical impact of sexual dimorphism in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Liver Int 2021;41:1713-1733.
crossref pmid pdf
25. Shi Y, Wei L, Xing L, Wu S, Yue F, Xia K, et al. Sex difference is a determinant of gut microbes and their metabolites SCFAs/MCFAs in high fat diet fed rats. Curr Microbiol 2022;79:347.
crossref pmid pdf
26. Zhu Q, Qi N, Shen L, Lo CC, Xu M, Duan Q, et al. Sexual dimorphism in lipid metabolism and gut microbiota in mice fed a high-fat diet. Nutrients 2023;15:2175.
crossref pmid pmc
27. Org E, Mehrabian M, Parks BW, Shipkova P, Liu X, Drake TA, et al. Sex differences and hormonal effects on gut microbiota composition in mice. Gut Microbes 2016;7:313-322.
crossref pmid pmc pdf
28. Stapleton S, Welch G, DiBerardo L, Freeman LR. Sex differences in a mouse model of diet-induced obesity: the role of the gut microbiome. Biol Sex Differ 2024;15:5.
crossref pmid pmc pdf
29. Burgueño AL, Gianotti TF, Mansilla NG, Pirola CJ, Sookoian S. Cardiovascular disease is associated with high-fat-dietinduced liver damage and up-regulation of the hepatic expression of hypoxia-inducible factor 1α in a rat model. Clin Sci (Lond) 2013;124:53-63.
crossref pmid pdf
30. Lu Y, Zhou G, Ewald J, Pang Z, Shiri T, Xia J. MicrobiomeAnalyst 2.0: comprehensive statistical, functional and integrative analysis of microbiome data. Nucleic Acids Res 2023;51:W310-W318.
crossref pmid pmc pdf
31. McDonald D, Price MN, Goodrich J, Nawrocki EP, DeSantis TZ, Probst A, et al. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J 2012;6:610-618.
crossref pmid pmc pdf
32. Dhariwal A, Chong J, Habib S, King IL, Agellon LB, Xia J. MicrobiomeAnalyst: a web-based tool for comprehensive statistical, visual and meta-analysis of microbiome data. Nucleic Acids Res 2017;45:W180-W188.
crossref pmid pmc
33. Herp S, Raj ACD, Silva MS, Woelfel S, Stecher B. The human symbiont Mucispirillum schaedleri: causality in health and disease. Med Microbiol Immunol 2021;210:173-179.
crossref pmid pmc pdf
34. Berry D, Kuzyk O, Rauch I, Heider S, Schwab C, Hainzl E, et al. Intestinal microbiota signatures associated with inflammation history in mice experiencing recurring colitis. Front Microbiol 2015;6:1408.
crossref pmid pmc
35. Lawal SA, Voisin A, Olof H, Bording-Jorgensen M, Armstrong H. Diversity of the microbiota communities found in the various regions of the intestinal tract in healthy individuals and inflammatory bowel diseases. Front Immunol 2023;14:1242242.
crossref pmid pmc
36. Kwon YJ, Kwak HJ, Lee HK, Lim HC, Jung DH. Comparison of bacterial community profiles from large intestine specimens, rectal swabs, and stool samples. Appl Microbiol Biotechnol 2021;105:9273-9284.
crossref pmid pdf
37. Leite GGS, Weitsman S, Parodi G, Celly S, Sedighi R, Sanchez M, et al. Mapping the segmental microbiomes in the human small bowel in comparison with stool: a REIMAGINE study. Dig Dis Sci 2020;65:2595-2604.
crossref pmid pmc pdf

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: cmh_journal@ijpnc.com
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 770
TOTAL : 2573519
Close layer